There is growing evidence showing that three-dimensional (3D) culture systems better represent a physiological environment. The physiological environment created by 3D culture systems facilitate more accurate responses to newly developed treatments or more generally administered chemical compounds than conventional two-dimensional culture substrates. Screvo B.V. has developed proprietary 3D high-throughput screening systems for a broad range of in vitro and in vivo research. Screvo’s proprietary technology offers an opportunity to improve the output of preclinical research, while decreasing the social and economic impact of animal experimentation.
- Pre-Seed Grant 2011